Quick Answer
GILEAD SCIENCES, INC. reported Revenue (ASC 606) of $29.44 billion for fiscal year 2025.
GILEAD SCIENCES, INC. Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $29.44B | +2.4% |
| 2024 | $28.75B | +6.0% |
| 2023 | $27.12B | -0.6% |
| 2022 | $27.28B | -0.1% |
| 2021 | $27.30B | +10.6% |
| 2020 | $24.69B | +10.0% |
| 2019 | $22.45B | +1.5% |
| 2018 | $22.13B | -15.2% |
| 2017 | $26.11B | -14.1% |
| 2016 | $30.39B | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $7.77B | +3.0% | +9.7% |
| June 30, 2025 | $7.08B | +1.8% | +6.2% |
| March 31, 2025 | $6.67B | -0.3% | -11.6% |
| September 30, 2024 | $7.54B | +7.0% | +8.5% |
| June 30, 2024 | $6.95B | +5.4% | +4.0% |
| March 31, 2024 | $6.69B | +5.3% | -5.2% |
| September 30, 2023 | $7.05B | +0.1% | +6.8% |
| June 30, 2023 | $6.60B | +5.4% | +3.9% |
- GILEAD SCIENCES, INC. showed an increase of +2.4% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2016–2025 period, GILEAD SCIENCES, INC.’s revenue (asc 606) has declined by 3.1% (from $30.39 billion to $29.44 billion).
- The most recent figure is from GILEAD SCIENCES, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: